Yan Wu

6PUBLICATIONS
39CO-AUTHORS
Haematological tumoursTumour immunologyGene and molecular therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 13, 2025
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance.

Cheng Zhong, Lixiang Wang, Yujia Liu

|Mar 21, 2025
AMPK-dependent Parkin activation suppresses macrophage antigen presentation to promote tumor progression.

Xinyu Wang, Yiyi Li, Yan Li

|Jan 09, 2025
Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC.

Kaiting Chen, Xiaochen Li, Shuyi Dong

|Oct 19, 2023
FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC.

Jie Liu, Yeling Ouyang, Zijin Xia

|Jan 07, 2022
A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors.

Diyuan Xue, Benjamin Moon, Jing Liao

|Dec 06, 2019
Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma.

Jing Liao, Dan-Ni Zeng, Jin-Zhu Li

Pageof 1

Frequent Collaborators

2 joint publications

Cheng Zhong

2 joint publications

Wei Yi

2 joint publications

Yujia Liu

2 joint publications

Yongyi Feng